Home

Tatva Chintan Pharma Chem Ltd PE Ratio

Image

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

PE

118.4

Last updated on: Apr 20, 2025

Key Highlights

  • The P/E Ratio of Tatva Chintan Pharma Chem Ltd is 118.4 as of 20 Apr 15:30 PM .
  • The P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 83.2 on March 2024 . This represents a CAGR of 15.93% over 3 years.
  • The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 723.65 as of 17 Apr 15:30 .
  • The PE Ratio of Chemicals Industry has changed from 11.3 to 51.5 in 5 years. This represents a CAGR of 35.44%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Chemicals industry is 51.5. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Tatva Chintan Pharma Chem Ltd

No data available

Company Fundamentals for Tatva Chintan Pharma Chem Ltd

Image

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

Share Price

₹ 723.65

1.00 (0.14%)

stock direction

Last updated on: Apr 17, 2025

Market Price of Tatva Chintan Pharma Chem Ltd

1M

1Y

3Y

5Y

Monitoring Tatva Chintan Pharma Chem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 2025723.65
16 Apr 2025722.65
15 Apr 2025710.9
11 Apr 2025695.4
09 Apr 2025650.1
08 Apr 2025664.5
07 Apr 2025654.1
04 Apr 2025685.5
03 Apr 2025711.45
02 Apr 2025726.35

SWOT Analysis Of Tatva Chintan Pharma Chem Ltd

Strength

3

che

Weakness

2

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Tatva Chintan Pharma Chem Ltd

Asset Value vs Market Value of Tatva Chintan Pharma Chem Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Tatva Chintan Pharma Chem Ltd1692
Pidilite Industries Ltd154329
SRF Ltd88612
Linde India Ltd53164
Gujarat Fluorochemicals Ltd43603
Godrej Industries Ltd38018

PE Ratio of Tatva Chintan Pharma Chem Ltd Explained

1692

Market cap

14

Earnings

118.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Chemicals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Tatva Chintan Pharma Chem Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in %

About Tatva Chintan Pharma Chem Ltd

  • Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
  • The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
  • The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
  • The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), , Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

Tatva Chintan Pharma Chem Ltd News Hub

Tatva Chintan Pharma Chem AGM scheduled

Tatva Chintan Pharma Chem announced that the Annual General Meeting (AGM) of the company will be hel

Read more

28 Aug 24

Tatva Chintan Pharma Chem to discuss results

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 25 October

Read more

17 Oct 24

Tatva Chintan Pharma Chem reports consolidated net loss of Rs 0.66 crore in the September 2024 quarter

Net loss of Tatva Chintan Pharma Chem reported to Rs 0.66 crore in the quarter ended September 2024

Read more

25 Oct 24

Tatva Chintan Pharma Chem consolidated net profit declines 95.95% in the December 2024 quarter

Net profit of Tatva Chintan Pharma Chem declined 95.95% to Rs 0.14 crore in the quarter ended Decemb

Read more

28 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Tatva Chintan Pharma Chem Ltd

What is the current PE Ratio of Tatva Chintan Pharma Chem Ltd?

The Current PE Ratio of Tatva Chintan Pharma Chem Ltd is 118.44 as on 20 Apr 2025.

What is the average PE Ratio of the Chemicals industry?

The average industry PE Ratio of Chemicals is 51.5 as on 20 Apr 2025.

What was the PE Ratio of Tatva Chintan Pharma Chem Ltd last year?

The PE Ratio of Tatva Chintan Pharma Chem Ltd was 81.23 last year, now the PE ratio is 118.44, showing a year-on-year growth of 45.8%.

What does the PE Ratio of Tatva Chintan Pharma Chem Ltd indicate about its stock?

The PE Ratio of Tatva Chintan Pharma Chem Ltd is 118.44. This ratio indicates that investors are willing to pay 118.44 times the earnings per share for each share of Tatva Chintan Pharma Chem Ltd.

What is the PE Ratio Growth of Tatva Chintan Pharma Chem Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Tatva Chintan Pharma Chem Ltd grew by 45.8% whereas, the EPS ratio grew by -120.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions